Rare diseases
Investigational molecules
Locations
Back to France951 clinical trials in Nantes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
FranceStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
FranceStudy on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer
FranceStudy Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement
FranceStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
FranceStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
FranceStudy on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis
FranceStudy of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients
FranceStudy on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation
FranceStudy on Long-term Safety of Satoreotide Tetraxetan Lutetium-177 for Patients with Somatostatin Receptor Positive Neuroendocrine Tumors
FranceStudy on Immunotherapy with Nivolumab and Ipilimumab for Patients with Recurrent Head and Neck Cancer After Surgery
FranceStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on multiple myeloma, leukemia, and various lymphomas. Studies are evaluating novel treatment combinations and therapeutic approaches for blood cancers.
Innovative trials exploring combinations of targeted therapies and immunotherapies to improve patient outcomes.
Comprehensive studies on preventive measures against viral infections, including trials for vaccines targeting CMV, yellow fever, and mpox.
Focus on developing and evaluating new vaccine formulations and delivery methods.
Research investigating treatments for inflammatory bowel diseases and multiple sclerosis, including innovative approaches like fecal microbiota transplantation.
Exploring novel therapeutic options and treatment de-escalation strategies.
Studies addressing postoperative care and management of severe conditions in intensive care settings, including burns and immune suppression.
Evaluating new approaches to improve patient comfort and outcomes in critical care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
